Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 [Phase 1]

View source ↗

Summary

This Phase 1 study of CMG901 in patients with advanced solid tumors, including gastric cancer and pancreatic cancer, assesses safety, tolerability, pharmacokine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• CMG901

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Advanced Solid Tumor, Gastric Cancer(Including Gastroesophageal Junction Adenocarcinoma) | Phase 1 | Status: COMPLETED